MX2022002993A - Rebamipida para usarse en la prevencion y/o tratamiento de la rigidez arterial. - Google Patents

Rebamipida para usarse en la prevencion y/o tratamiento de la rigidez arterial.

Info

Publication number
MX2022002993A
MX2022002993A MX2022002993A MX2022002993A MX2022002993A MX 2022002993 A MX2022002993 A MX 2022002993A MX 2022002993 A MX2022002993 A MX 2022002993A MX 2022002993 A MX2022002993 A MX 2022002993A MX 2022002993 A MX2022002993 A MX 2022002993A
Authority
MX
Mexico
Prior art keywords
rebamipide
prevention
treatment
arterial stiffness
arterial
Prior art date
Application number
MX2022002993A
Other languages
English (en)
Inventor
Ivan Danek
Original Assignee
Square Power Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Square Power Ltd filed Critical Square Power Ltd
Publication of MX2022002993A publication Critical patent/MX2022002993A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere al uso de rebamipida en un método de prevención y/o tratamiento de la rigidez arterial y enfermedades relacionadas, tal como hipertensión, insuficiencia cardíaca, infarto de miocardio, accidente cerebrovascular, enfermedad arterial periférica, insuficiencia renal y enfermedad renal crónica; la rebamipida también se puede utilizar en un método para incrementar la elasticidad arterial.
MX2022002993A 2019-09-11 2020-09-10 Rebamipida para usarse en la prevencion y/o tratamiento de la rigidez arterial. MX2022002993A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19020528.6A EP3797774A1 (en) 2019-09-11 2019-09-11 Rebamipide for use in prevention and/or treatment of arterial stiffness
PCT/EP2020/075399 WO2021048314A1 (en) 2019-09-11 2020-09-10 Rebamipide for use in prevention and/or treatment of arterial stiffness

Publications (1)

Publication Number Publication Date
MX2022002993A true MX2022002993A (es) 2022-06-08

Family

ID=67956439

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002993A MX2022002993A (es) 2019-09-11 2020-09-10 Rebamipida para usarse en la prevencion y/o tratamiento de la rigidez arterial.

Country Status (11)

Country Link
US (1) US20220304999A1 (es)
EP (1) EP3797774A1 (es)
JP (1) JP2022549770A (es)
KR (1) KR20220062008A (es)
CN (1) CN114340627A (es)
AU (1) AU2020347481A1 (es)
BR (1) BR112022003917A2 (es)
CA (1) CA3152961A1 (es)
MX (1) MX2022002993A (es)
WO (1) WO2021048314A1 (es)
ZA (1) ZA202203554B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014021637A1 (ko) * 2012-07-31 2014-02-06 가톨릭대학교 산학협력단 레바미피드를 유효성분으로 포함하는 고지혈증 및 이와 관련된 질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
US20220304999A1 (en) 2022-09-29
WO2021048314A1 (en) 2021-03-18
BR112022003917A2 (pt) 2022-05-31
AU2020347481A1 (en) 2022-04-21
CN114340627A (zh) 2022-04-12
JP2022549770A (ja) 2022-11-29
CA3152961A1 (en) 2021-03-18
ZA202203554B (en) 2023-11-29
EP3797774A1 (en) 2021-03-31
KR20220062008A (ko) 2022-05-13

Similar Documents

Publication Publication Date Title
BR112015009948A2 (pt) antagonistas de ativina-actriia e usos para tratamento ósseos e outros disturbios
EA201300583A1 (ru) Вазопротективное и кардиопротективное противодиабетическое лечение
MY157525A (en) Inhibitors of the renal outer medullary potassium channel
WO2015077540A3 (en) Compositions and methods for treating pulmonary hypertension
EA200970944A1 (ru) Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов
MD3762368T2 (ro) Compuși diol aminopirazină ca inhibitori ai PI3K-Y
MX2017000635A (es) Inhibidores del canal de potasio medular externo renal.
EA201101231A1 (ru) Способы предотвращения или снижения риска смертности
EA202190841A1 (ru) Композиции для снижения уровней мочевой кислоты в сыворотке крови
WO2015095097A3 (en) Inhibitors of the renal outer medullary potassium channel
EA201991676A1 (ru) Ингибиторы nhe-опосредованного антипорта
EA201791021A1 (ru) 1-[2-(АМИНОМЕТИЛ)БЕНЗИЛ]-2-ТИОКСО-1,2,3,5-ТЕТРАГИДРО-4H-ПИРРОЛО[3,2-d]ПИРИМИДИН-4-ОНЫ КАК ИНГИБИТОРЫ МИЕЛОПЕРОКСИДАЗЫ
MX2020013301A (es) Metodos y composiciones para prevenir o tratar calcifilaxis.
MX2017000634A (es) Inhibidores del canal de potasio medularmente externo renal.
MA38369A1 (fr) Peptides et compositions pour le traitement d'une lesion de l'articulation
MX2022002638A (es) Proteinas de fusion terapeuticas.
MX2018008614A (es) Inhibidores de il-8 para usarse en el tratamiento de neuropatia periferica inducida por quimioterapia.
MX2022002993A (es) Rebamipida para usarse en la prevencion y/o tratamiento de la rigidez arterial.
MX2022004049A (es) Tratamiento basado en biomarcadores de la glomeruloesclerosis focal y segmentaria y de la enfermedad renal diabetica.
EA202191150A1 (ru) Ингибиторы аминопептидазы а и содержащие их фармацевтические композиции
EA202191151A1 (ru) Новые аминофосфиновые производные в качестве ингибиторов аминопептидазы а
WO2020142740A8 (en) Treatment of sjogren's disease with nuclease fusion proteins
MX2021000976A (es) Compuestos para usarse en el tratamiento de trastornos renales.
MD3638370T2 (ro) Tratamentul migrenei cu acetil-leucină
MX2008009161A (es) Tratamiento de enfermedad cardiovascular en mexicano-americanos, usando nebivolol.